Conbody VS Everybody,” a five-part documentary series from director Debra Granik, will premiere on the Criterion Channel. It ...

A former world champion who is destined for the Hall of Fame someday has lost 144 pounds. Find out how he dramatically ...

At SXSW, Noah Kahan debuted a beautiful and revealing documentary about his struggles with fame, depression and body ...

Former ‘America’s Next Top Modeling’ contestant Keenyah Hill recalled feeling pressure to ‘lose a bunch of weight’ to pursue ...

The Ozempic Effect originally premiered in 2025, but only landed on Netflix UK last Friday (February 27). It explores the use ...

Planning for major weight loss may soon become an easier pill − or balloon − to swallow. As manufacturers ramp up for a GLP-1 legal battle and every food brand seems to be releasing new protein-packed ...

Feb 23 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...

CagriSema shows 23% weight loss versus 25.5% for Zepbound Novo's shares drop 15% Lilly's shares rise 4% in US pre-market trading Outcome is 'worst-case scenario' for Novo, investor says Few analysts ...

Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi-dose KwikPen, giving patients a simpler way to receive a full month ...